Article metrics

Original research
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

 

Online download statistics by month:

Online download statistics by month: April 2022 to May 2022

AbstractFullPdf
Apr 202211001134482
May 20229671006326
Total20672140808